Evaluation of methicillin-resistant Staphylococcus aureus nasal carriage in Malagasy patients

Journal of Infection in Developing Countries

Volumn 7, Issue 4, 2013, Pages 318-322

  Rasamiravaka, Tsiry ^a   Rasoanandrasana, Saida ^a   Zafindraibe, Norosoa Julie ^a   Rakoto Alson, Aimée Olivat ^a   Rasamindrakotroka, Andry ^a  

^a UNIVERSITY OF ANTANANARIVO   (Madagascar)

Author keywords

Malagasy lab; MRSA; Nasal carriage; Risk factors

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LINCOMYCIN; OFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; DISEASE ASSOCIATION; FEMALE; HUMAN; MADAGASCAR; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; QUESTIONNAIRE; RISK FACTOR;

ADOLESCENT; ADULT; CARRIER STATE; CONFIDENCE INTERVALS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FEMALE; HOSPITALIZATION; HUMANS; MADAGASCAR; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NOSE; OFLOXACIN; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84876364187     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2460     Document Type: Article

References (17)

1. Williams REO (1963) Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 27: 56-71.
2. Noble WC, Valkenburg HA, Wolters CH (1967) Carriage of Staphylococcus aureusin random samples of a normal population. J Hyg Lond 65: 567-573.
3. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev10: 505-520.
4. Eriksen NH, Espersen F, Rosdahl VT, Jensen K (1995) Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 115:51-60.
5. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA(2004) Risk and outcome of nosocomial Staphylococcus aureusbacteraemia in nasal carriers versus non-carriers. Lancet364: 703-705.
6. Randrianirina F, Soares JL, Ratsima E, Carod JF, Combe P, Grosjean P, Richard V, Talarmin A (2007) In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar. Ann Clin Microbiol Antimicrob 6: 5.
7. Baird Parker AC (1962) An improved diagnostic and selective medium for isolating coagulase-positive Staphylococci. J Appl Bact 25: 12-19.
8. Hutchison MJ, Edwards GFS, Morrison D (2005) Evaluation of chromogenic MRSA selective screening media, poster by Scottish MRSA Reference Laboratory presented at the 2005 Institute of Bio Medical Sciences Annual Conference.
9. Skov R, Smyth R, Larsen AR, Bolmstrom A, Karlsson A, Mills K, Frimodt-Moller N (2007) Comité de l'Antibiogramme de la Société Française de Microbiologie: Recommandations 2007. Paris, France.
10. Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36: 131-139.
11. Landers TF, Harris RE, Wittum TE, Stevenson KB (2009) Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, Ohio. Infect Control Hosp Epidemiol 30: 801-803.
12. White A (1961) Quantitative studies of nasal carriers of staphylococci among hospitalized patients. J Clin Invest 40: 23-30.
13. Al-Rawahi GN, Schreader AG, Porter SD, Roscoe DL, Gustafson R, Bryce EA (2008) Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: Six years later. J Clin Microbiol 46: 477-479.
14. Weese J, Rousseau J, Traub-Dargatz J, Willey B, McGeer A, Low D (2005) Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc 226: 580-583.
15. Goslings WR, Buchli K (1958) Nasal carrier rate of antibiotic-resistant staphylococci; influence of hospitalization on carrier rate in patients, and their household contacts. AMA Arch Intern Med 102: 691-715.
16. Graffunder EM, and Venezai RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49: 999-1005.
17. CLSI (2007) Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.